Who is sponsoring NCT02694510?

NCT02694510 is sponsored by Mansoura University Children Hospital.

What drugs are being tested in NCT02694510?

Interventions in NCT02694510: Light-protection of TPN solutions.

What condition does NCT02694510 study?

NCT02694510 studies Oxidative Stress in Preterm Infants.

Is NCT02694510 still recruiting?

NCT02694510 is currently completed. Last updated 26 January 2018.

Last reviewed 2018-01-26 · How we verify

NCT02694510

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Light Protection of TPN and Oxidative Stress in Preterm Infants

Completed NA Last updated 26 January 2018

What this trial tests

NA trial testing Light-protection of TPN solutions in Oxidative Stress in Preterm Infants in 80 participants. Completed in 1 January 2018.

Timeline

1 January 2014

Primary endpoint
1 January 2018

1 January 2018

Quick facts

Lead sponsor	Mansoura University Children Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	80
Start date	1 January 2014
Primary completion	1 January 2018
Estimated completion	1 January 2018
Sites	1 location across Egypt

Drugs / interventions tested

Light-protection of TPN solutions

Conditions studied

Oxidative Stress in Preterm Infants — all drugs for Oxidative Stress in Preterm Infants →

Sponsor

Mansoura University Children Hospital

Who can join

Adults 24 Hours to 7 Days, any sex, with Oxidative Stress in Preterm Infants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Urinary peroxides and plasma glutathione/glutathione disulfide (GSH/GSSG) ratio will be measured in preterm infants less than 32 weeks gestation before and 7 days after receiving either Light-protected (Group 1) or Light-exposed (Group 2) Total Parenteral Nutrition (TPN) solutions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mansoura University Children Hospital trials

Trials by the same sponsor.

NCT05589909 — Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis · unknown
NCT04474327 — Role of Montelukast in Modulation of Response to Sepsis in Preterm Infants · Phase 1 · completed
NCT03731611 — Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency · NA · completed
NCT05091008 — Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children · Phase 2 · completed
NCT05596656 — IgE-mediated Allergies Among Type 1 Diabetes Mellitus Children, Single Centre Observational Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02694510 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University Children Hospital
Last refreshed: 26 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02694510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing